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.2012.01.0Abstract The reaction of 6-amino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione (1) as a binucleophile
with primary aromatic or heterocyclic amines and formaldehyde or aromatic (heterocyclic)
aldehydes in a molar ratio (1:1:2) gave the pyrimido[4,5-d]pyrimidin-2,4-dione ring systems 2–5.
Treatment of 1 with diamines and formalin in molar ratio (2:1:4) gave the bis-pyrimido[4,5-d]pyr-
imidin-2,4-diones 6–8. Furthermore, substituted pyrimido[4,5-d]pyrimidin-2,4-diones with uracil
derivative 11 or spiro indole 16 were synthesized. Synthesis of pyrimido[4,5-d]pyrimidin-2,4-diones
with different substitution at C-5 and C-7 was achieved to give 13 and 18, respectively.
ª 2012 Cairo University. Production and hosting by Elsevier B.V. All rights reserved.Introduction
A large number of pyrimidine derivatives were reported to ex-
hibit interesting pharmacological activity [1–8]. A class of com-
pounds of biological relevance was used in the plant protection
area as plant growth regulators [9]. In continuation of our
studies, the development of expedient methods for the synthe-
sis of pyrimido[4,5-d]pyrimidine-2,4-dione, were implemented
[10]. Pyrimidopyrimidines are annulated uracils that have at-242388; fax: +20 502246254.
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01tracted considerable interest in recent years. Derivatives of
pyrimidopyrimidine are known to display a wide range of
pharmacological activities, and their potent inhibitory proper-
ties regarding the tyrosine kinase domain of epidermal growth
factor receptor [11], 5-phosphoribosyl-1-pyrophosphate syn-
thetase [12] and dihydrofolate-reductase [13], have been fully
demonstrated. Numerous reports delineate the antitumour
[14], antiviral [15], antioxidant [16], antifungal [17] and hepato-
protective [18] activities. The multicomponent reactions
(MCR’s) [19,20], are masterpieces of synthetic efﬁciency and
reaction design.Experimental
All melting points were measured on a Gallenkamp electric
melting point apparatus. Infrared spectra measured using
KBr discs on a Mattson 5000 FTIR spectrometer at the
Microanalytical Center (Cairo University, Egypt). The 1H.V. All rights reserved.
116 W.S. Hamama et al.NMR and 13C NMR spectra were carried out on Varian
Gemini 200 MHz spectrophotometer, Microanalytical center
(Cairo University, Egypt), using TMS as an internal standard
and chemical shifts were recorded in ppm on d scale and cou-
pling constants (J) are given in Hz. The mass spectra recorded
on a GC–MS (Shimadzu QP-1000 EX). Reactions were mon-
itored by thin layer chromatography (TLC) using silica gel
(EM science) coated plates. The starting 6-amino-1,3-dimeth-
ylpyrimidine-2,4(1H,3H)-dione (1) was purchased from Al-
drich Company. Elemental analyses were measured with a
ECS 4010 Elemental combustion system instrument at the
Microanalytical Unit, Faculty of Science, Cairo University;
their results were found to be in good agreement with the cal-
culated values.Synthesis of pyrimido[4,5-d]pyrimidone ring systems 2–5
General procedure: A solution of 6-amino-1,3-dimethylpyrimi-
dine-2,4(1H,3H)-dione (1) (1.01 g, 6.5 mmol) in ethanol
(30 mL) was added to a mixture of amines [p-anisidine (0.8 g,
6.5 mmol), m-nitroaniline (0.898 g, 6.5 mmol), p-anisidine
(0.8 g, 6.5 mmol), or 2-aminothiazole (0.65 g, 6.5 mmol)] and
aldehydes [formaldehyde (0.39 g, 13 mmol), piperonal (1.95 g,
13 mmol), p-anisaldehde (1.77 g, 13 mmol), or furfural
(1.25 g, 13 mmol)] in ethanol (20 mL). The reaction mixture
was stirred at 35 C for 2 h, then left to stand at room temper-
ature for 3 days. The resulting precipitate was collected by ﬁl-
tration, dried and puriﬁed by crystallization from ethanol to
give the corresponding products 2–5, respectively.6-(4-Methoxyphenyl)-1,3-dimethyl-5,6,7,8-
tetrahydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione (2)
Recrystallization from ethanol to give (25%) 2; white crystals.
M.p.: 160 C; Rf = 0.7 [pet. ether 40–60 C/ethyl acetate,
(1:2)]; IR (KBr): V= 3257 (NH), 2971 (CH, str.), 1677, 1621
(CO), 1511 cm1 (C@C); 1H NMR (200 MHz, DMSO):
d= 3.32 (s, 3H, NCH3), 3.73 (s, 3H, OCH3), 4.59 (s, 2H,
CH2), 5.04 (s, 1H, NH–CH2–N), 6.3 (br, 1H, NH), 6.65–7.12
(m, 12H, Ar–H); MS (m/z) (I%) = 302 (M+, 24), 303
(M++1, 5), 288 (13), 285 (3), 242 (1), 214 (1), 155 (5), 137
(2) 135 (100), 121 (10), 120 (54), 107 (3), 91 (2); Calc for
(C15H18N4O3) C, 59.59; H, 6.00; N, 18.53; Found C 59.63,
H, 5.97, N 18. 47.5,7-Di(benzo[d][1,3]dioxol-5-yl)-1,3-dimethyl-6-(3-nitro-
phenyl)-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidine-
2,4(1H,3H)-dione (3)
Recrystallization from ethanol to give to give (35%) 3; yellow
crystals. M.p.: 212 C; Rf = 0.57 [pet. ether 40–60 C/ethyl
acetate, (1:2)]; IR (KBr): V= 3424 (NH), 1700, 1618 (CO),
1530 cm1 (C@C); 1H NMR (200 MHz, DMSO): d= 3.32
(s, 3H, CH3), 3.37 (s, 3H, CH3), 4.6 (s, 4H, 2CH2), 5.4 (s,
1H, CH), 5.8 (s, 1H, CH), 6.9 (br., 1H, NH), 7.1–7.5 (m, 10
H, Ar–H); MS (m/z) (I%)= 555 (M+2, 2), 380 (1), 313
(1), 288 (1), 196 (2), 138 (2), 137 (100), 65 (3); Calc for
(C28H23N5O8) C, 60.32; H, 4.16; N, 12.56; Found C, 60.39;
H, 4.23; N, 12.48.5,6,7-Tris(4-methoxyphenyl)-1,3-dimethyl-5,6,7,8-
tetrahydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione (4)
Recrystallization from ethanol to give (93%) 4; white crystal.
M.p.: 130 C; Rf = 0.56 [pet. ether 40–60 C/ethyl acetate,
(1:1)]; IR (KBr): V= 3402 (NH), 3129, 2948 (CH, str.),
1625 cm1 (CO); 1H NMR (200 MHz, DMSO): d= 3.32 (s,
6H, 2NCH3), 3.73 (s, 9H, 3OCH3), 4.59 (s, 1H, CH), 5.04 (s,
1H, NH–CH), 6.3 (br., 1H, NH), 6.65-7.1 (m, 12H, Ar–H);
MS (m/z) (I%) = 514 (M+, 14), 330 (30), 253 (20), 193 (44),
175 (43), 122 (100); Calc for (C29H30N4O5) C, 67.69; H, 5.88;
N, 10.89; Found C, 67.74; H, 5.93; N, 10.78.
5,7-Di(furan-2-yl)-1,3-dimethyl-6-(thiazol-2-yl)-5,6,7,8-
tetrahydro-pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione (5)
Recrystallization from ethanol to give (31%) 5; green crystals.
M.p.: 325 C; Rf = 0.46 [pet. ether 40–60 C/ ethyl acetate
(1:2)]; IR (KBr): V= 3418, 3357 (NH), 3144, 2955 (CH,
str.), 1675, 1615 (CO), 1554 cm1 (C‚C); 1H NMR
(200 MHz, DMSO): d= 3.35 (s, 3H, NCH3), 3.77 (s, 3H,
OCH3), 4.59 (s, 1H, CH), 5.04 (s, 1H, N–CH–N), 6.45 (br,
1H, NH), 6.65–7.16 (m, 12H, Ar–H); MS (m/z) (I%)= 411
(M+, 17), 383 (21), 354 (8), 271 (20), 225 (18), 178 (2), 55
(100); Calc for (C19H17N5O4S) C, 55.47; H, 4.16; N, 17.02;
Found C, 55.38; H, 4.23; N, 17.00.
General procedure for the synthesis of bis-pyrimido[4,5-d]pyr-
imidones ring system 6, 7 and 8
A solution of 1 (1.01 g, 6.5 mmol) in ethanol (30 mL) was
added to a solution of formaldehyde (13 mmol, 40% solution)
with diamine namely; p-phenylenediamine (0.35 g, 3.25 mmol),
ethane-1,2-diamine (0.195 g, 3.25 mmol) and hydrazine hy-
drate (0.16 g, 3.25 mmol) in ethanol (20 mL), the reaction mix-
ture was stirred for 2 h then left to stand at room temperature
for 3 days. The resulting precipitate was collected by ﬁltration,
then puriﬁed by recrystallization from ethanol to gave bis-
pyrimido[4,5-d]pyrimidines 6-8, respectively.
6-(4-(6,8-Dimethyl-5,7-dioxooctahydropyrimido[4,5-
d]pyrimidin-3(4H)-yl)phenyl)-1,3-dimethyl-5,6,7,8-
tetrahydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione (6)
Recrystallization from ethanol to give (39%) 6; green crystals.
M.p.: 224 C; Rf = 0.5 [pet. ether 40–60 C/ethyl acetate (1:2)];
IR (KBr): V= 3399, 3358 (NH), 3225 (CH, str.) 1687, 1658
(CO), 1607 cm1 (C‚C); 1H NMR (200 MHz, DMSO):
d= 3.12 (s, 3H, CH3), 3.16 (s, 3H, CH3), 3.17 (s, 3H, CH3),
3.2 (s, 3H, CH3), 3.94 (s, 4H, 2CH2), 4.51 (s, 4H, 2CH2),
6.5–6.9 (m, 4H, Ar–H), 7.3 (br., 2H, 2NH); MS (m/z)
(I%) = 465 (M+1, 2), 461 (2), 311 (10), 272 (2), 196 (4),
181 (3), 168 (6), 154 (10), 120 (100); Calc for (C22H28N8O4)
C, 56.40; H, 6.02; N, 23.92; Found C, 56.57; H, 6.08; N, 24.01.
6-(2-(6,8-Dimethyl-5,7-dioxooctahydropyrimido[4,5-
d]pyrimidin-3(4H)-yl)ethyl)-1,3-dimethyl-5,6,7,8-
tetrahydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione (7)
Recrystallization from ethanol to give (40%) 7; white crystals.
M.p.: 255 C; Rf = 0.76 [pet. ether 40–60 C/ethyl acetate,
Novel Pyrimido[4,5-d]pyrimidones 117(1:1)]; IR (KBr): V= 3402 (NH), 3129 (CH, str.), 1692, 1670,
1620 cm1 (CO); 1H NMR (200 MHz, DMSO): d= 3.12 (s,
6H, 2CH3), 3.21 (s, 6H, 2CH3), 3.29 (t, J= 6.4 Hz, 4H,
2CH2), 3.42 (s, 4H, 2CH2), 4.02 (s, 4H, 2CH2), 7.1 (br., 2H,
2NH); MS (m/z) (I%)= 209 (M+2, 5), 222 (4), 196 (2),
140 (7), 56 (35), 55 (100); Calc for (C18H28N8O4) C, 51.42;
H, 6.71; N, 26.65; Found C, 51.47; H, 6.74; N, 26.72.
6,60,8,80-Tetramethyl-40,40a-dihydro-1H,10H-3,30-bipyrimido-
[4,5-d]pyrimidine-5,50,7,70(2H,20H,4H,6H,60H,8H,80H,80aH)-
tetraone (8)
Recrystallization from ethanol to give (40%) 8; white crystals.
M.p.: 230–233 C; Rf = 0.58 [pet. ether 40–60 C/ethyl acetate
(1:2)]; IR (KBr): V= 3402 (NH), 3135, 2948 (CH, str.), 1693,
1680 (CO), 1584 cm1 (C‚C); MS (m/z) (I%)= 390 (M+2,
2), 371 (2), 357 (3), 322 (35), 304 (5), 233 (6), 190 (4), 168 (100),
111 (2), 57 (76); Calc for (C16H24N8O4) C, 48.97; H, 6.16; N,
28.56; Found C, 48.93; H, 6.19; N, 28.62.
Synthesis of 6-((6-amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-
tetrahydro-pyrimidin-5-yl)methyl)-1,3-dimethyl-5,6,7,8-
tetrahydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione (11)
A mixture of 10 (1.05 g, 3 mmol) and formaldehyde (2 mL,
40% solution) was heated at 60 C in ethanol (10 mL). The
reaction mixture was cooled, product ﬁltered, dried and crys-
tallized from ethanol to give (55%) 11; white crystals. M.p.:
150 C; IR (KBr): V= 3350, 3283 (NH2), 3209 (NH), 1695,
1677 cm1 (CO); 1H NMR (200 MHz, DMSO): d= 3.32 (s,
6H, 2CH3), 3.37 (s, 6H, 2CH3), 3.6 (s, 2H, NH2), 4.2 (s, 4H,
2CH2, pyrimidine), 4.3 (s, 2H, CH2), 6.3 (br., 1H, NH);
13C
NMR (200 MHz, DMSO): d= 162.8 (CO–N), 162.5 (CO–
N), 154.8, 152.6, 151.5, 83.3, 62.3, 45.9, 43.5, 31.0, 30.7,
29.7, 29.5; MS (m/z) (I%)= 363 (M+, 8), 303 (41), 304
(100), 209 (3), 208 (14), 192 (11), 154 (5); Calc for
(C15H21N7O4) C, 49.58; H, 5.83; N, 26.98; Found C, 49.62;
H, 5.72; N, 26.86.
Synthesis of secondary Mannich bases 12 and 15
General procedure: A mixture of 1 (1.01 g, 6.5 mmol), aldi-
mines namely; N-(4-chlorobenzylidene)-3-nitroaniline (1.69 g,
6.5 mmol) or 14 (1.44 g, 6.5 mmol) in ethanol (30 mL) contain-
ing three drops of acetic acid was heated under reﬂux for 9 h.
The reaction mixture was kept in refrigerator overnight where-
by the formed precipitate was ﬁltered off, dried and recrystal-
lized from appropriate to furnish compounds 12 and 15,
respectively.
6-Amino-5-((4-chlorophenyl)(3-nitrophenylamino)methyl)-
1,3-dimethyl-pyrimidine-2,4(1H,3H)-dione (12)
Recrystallized from acetic acid to give (45%) 12; yellow crys-
tals. M.p.: 260 C; Rf = 0.64 [pet. ether 40–60 C/ethyl acetate
(1:2)]; IR (KBr): V= 3350, 3225 (NH2), 3209 (NH), 3138
(CH, str.) 1693, 1668 (CO), 1592 cm1 (C‚C); 1H NMR
(200 MHz, DMSO): d= 3.1 (s, 3H, CH3) 3.3 (s, 3H, CH3),
5.57 (s, 1H, CH), 7.6 (br., 2H, NH2), 7.7–8.0 (m, 8H, Ar–H),
8.78 (s, 1H, NH); MS (m/z) (I%)= 415 (M+, 27), 413 (79),
278 (72), 276 (100), 242 (8), 166 (10), 155 (27), 137 (8); Calcfor (C19H18ClN5O4) C, 54.88; H, 4.36; N, 16.84; Found C,
54.69; H, 4.43; N, 16.79.
6-Amino-1,3-dimethyl-5-(2-oxo-3-(phenylamino)indolin-
3-yl)pyrimidine-2,4(1H,3H)-dione (15)
Recrystallized from acetic acid to give (54%) 15; yellow crys-
tals. M.p.: 330–332 C; Rf = 0.67 [chloroform/methanol
(1:4)]; IR (KBr): V= 3465, 3409 (NH2), 3282, 3198 (NH),
1754 (CO, isatin), 1696, 1689 (CO, amidic), 1600 cm1
(C‚C); 1H NMR (200 MHz, DMSO): d= 3.02 (s, 3H,
CH3), 3.18 (s, 3H, CH3), 6.95 (br., 2H, NH2), 6.98–7.32 (m,
9H, Ar–H), 9.36 (s, 1H, NH), 11.55 (br., 1H, NH); MS (m/z)
(I%) = 378 (M++1, 17), 313 (25), 285 (11), 153 (7), 152
(23), 133 (13), 91 (27), 57 (100), 56 (43); Calc for
(C20H19N5O3) C, 63.65; H, 5.07; N, 18.56; Found C, 63.59;
H, 5.16; N, 18.46.
Annulations of secondary Mannich bases: Synthesis of 13 and 16
A mixture of 12 (1.25 g, 3 mmol) or 15 (1.13 g, 3 mmol) and
formaldehyde (2 mL, 40% solution) was heated at 60 C in
ethanol (10 mL) for 3 h. The reaction mixture was cooled,
product ﬁltered, dried and recrystallized from ethanol to give
13 and 16, respectively.
5-(4-Chlorophenyl)-1,3-dimethyl-6-(3-nitrophenyl)-5,6,7,8-
tetrahydropyrimido[4,5-d] pyrimidine-2,4(1H,3H)-dione (13)
Recrystallized from ethanol to give (75%) 13; white crystals.
M.p.: 120 C; IR (KBr): V= 3314, 3181 (NH), 2922 (CH,
str.), 1651 (CO), 1600 cm1 (C‚C); MS (m/z) (I%)= 429
(M++1, 15), 372 (41), 310 (16), 256 (29), 222 (36), 165 (56),
52 (100); Calc for (C20H18ClN5O4) C, 56.15; H, 4.24; N,
16.37; Found C, 56.21; H, 4.32; N, 16.35.
60,80-Dimethyl-30-phenyl-20,30-dihydro-10H-spiro[indoline-3,40-
pyrimido[4,5-d]pyrimidine]-2,50,70(60H,80H)-trione (16)
Recrystallized from ethanol to give (45%) 16; white crystals.
M.p.: 190 C; IR (KBr): V= 3308, 3185 (2NH), 2983, 2921
(CH, str.), 1752, 1697, 1648 cm1 (CO); 1H NMR (200 MHz,
DMSO): d= 3.32 (s, 3H, CH3), 3.37 (s, 3H, CH3), 4.6 (s,
2H, CH2), 6.2 (br., s, 1H, CH2–NH), 7.1–7.52 (m, 9H, Ar–
H), 8.6 (s, 1H, CO–NH); 13C NMR (200 MHz, DMSO):
d= 168.7, 163.4, 155.1, 154.1, 149.6, 141.2, 129.9, 129.7,
127.8, 126.9, 122.0, 118.3, 114.3, 95.6, 63.6, 47.2, 30.9, 29.7;
MS (m/z) (I%)= 390 (M++1, 15), 368 (29), 358 (24), 264
(100), 227 (22); Calc for (C21H19N5O3) C, 64.77; H, 4.92; N,
17.98; Found C, 64.73; H, 4.83; N, 17.82.
Synthesis of 6-amino-1,3-dimethyl-2,4-dioxo-N-phenyl-1,2,3,4-
tetrahydro-pyrimidine-5-carbo-thioamide (17)
A mixture of 1 (1.01 g, 6.5 mmol) and phenyl isothiocyanate
(0.88 g, 6.5 mmol) in toluene (20 mL), was reﬂuxed for 9 h un-
til the disappearance of the starting materials as evidenced by
the TLC. The formed precipitate was collected by ﬁltration,
dried and crystallized from ethanol to give (55%) 17, yellow
crystals. M.p.: 300 C; Rf = 0.67 [chloroform: methanol
(5:1)]; IR (KBr): V= 3400, 3356 (NH2) 3227 (NH), 2948
118 W.S. Hamama et al.(CH, str.), 1660, 1613 (CO), 1236, 1213 (C‚S); MS (m/z)
(I%) = 290 (M+, 0.13), 257 (0.31), 222 (0.09), 154 (100), 136
(6.77), 127 (13.67), 82 (76.88), 77 (0.35); Calc for
(C13H14N4O2S) C, 53.78; H, 4.86; N, 19.30; Found C, 53.65;
H, 4.93; N, 19.26.
Synthesis of 1,3-dimethyl-6,7-diphenyl-5-thioxo-5,6,7,8-
tetrahydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione (18)
A mixture of 17 (0.87 g, 3 mmol) and benzyldehyde (0.32 g,
3 mmol) was reﬂuxed in ethanol (10 mL) for 3 h. The reaction
mixture was cooled, product ﬁltered, dried and crystallized
from ethanol to give (61%) 18, yellow crystal. M.p.: 125 C;
IR (KBr): V= 3068, 3005 (NH), 2880, 2834 (CH, str.),
1789, 1686 (CO), 1326, 1292 cm1 (C‚S); 1H NMR
(200 MHz, DMSO): d= 3.32 (s, 3H, CH3), 3.37 (s, 3H,
CH3), 5.06 (s, 1H, CH), 6.3 (s, 1H, NH), 6.5–7.3 (m, 10H,
Ar–H); MS (m/z) (I%) = 379 (M++1, 2), 378 (M+, 6), 331
(3), 269 (2), 256 (5), 213 (4), 105 (36), 55 (100); Calc for
(C20H18N4O2S) C, 63.47; H, 4.79; Found C, 63.53; H, 4.83.
Results and discussion
The objective of the present work was to investigate the behav-
ior of Mannich reaction towards 6-amino-1,3-dimethylpyrimi-H2N O
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Scheme 1 Reaction of 1 with primary amines adine-2,4(1H,3H)-dione (1) as a bifunctional nucleophile with
primary amines. Mannich reaction of 1 with primary aromatic
or heterocyclic amines, namely, p-anisidine and m-nitroaniline,
2-aminothiazole, aromatic and heterocyclic aldehydes, namely;
formaldehyde, piperonal, p-anisaldehyde as well as furfural in
a molar ratio (1:1:2) gave pyrimido[4,5-d]pyrimidine ring sys-
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methods to obtain pyrimido[4,5-d]pyrimidines have been re-
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[10,26,27] and to Roth & Hagen work [28]. The 1H NMR spec-
trum of 3 showed singlet signals at d 3.32 and 3.37 ppm for two
N–CH3 groups, singlet signals at d 4.6, 5.4 and 5.8 ppm due to
two (–O–CH2–O–), (CH–N) and (N–CH–N) groups, respec-
tively, broad signal at d 6.9 ppm for NH and multiplet signals
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Scheme 2 Synthesis of bis-pyrimido[4,5-d]pyrimidine ring systems 6-8.
Novel Pyrimido[4,5-d]pyrimidones 119groups, respectively, multiplet signals at d 6.5–6.9 for four aro-
matic protons and broad signal at d 7.3 ppm for two NH pro-
tons. Additionally, the mass spectra of compounds 6, 7 and 8
showed the molecular ion peaks at m/z 463 (M+2), 209
(M+2) and 390 (M+), respectively.
Therefore, 6-amino-1,3-dimethyl-5-(morpholinomethyl)
pyrimidine-2,4(1H,3H)-dione (9) [10], was trans-aminated with
ammonium carbonate to the symmetrical bis-Mannich base
10, which annulated by formalin to give 6-((6-amino-1,3-
dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl)-
1,3-dimethyl-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidine-2,4-
(1H,3H)-dione (11) (Scheme 3). The mass spectrum of 11
showed the molecular ion peak at m/z 363 (M+, 7.5%).
Another route was also accomplished to obtain the pyrim-
ido[4,5-d]pyrimidine derivative with different substitution at
C-5 and C-7 [since in Mannich reaction the new constructed
pyrimidine moieties have symmetrical substitutions at C-5
and C-7 according to the aldehyde used]. Therefore, the pres-
ent work has focused on the reaction of 1 with aldimine or ket-
imine as a route to the corresponding secondary Mannich1
N
N
O
O
CH3
H3C
NH2
9
N
O
(NH4)2CO
Scheme 3 Synthesis of pyrimbases [27,28]. Treatment of 1 with N-(4-chlorobenzylidene)-3-
nitroaniline afforded 12. Additionally, compound 12 was
annulated with formalin to afford the target compounds 13.
The assigned structure 12 was established on the basis of ana-
lytical and spectral data. Its mass spectrum showed the molec-
ular ion peak at m/z 415 (M+, 26.5) and 413 (M+2, 78.7) by
relative intensity (1:3). In addition, treatment of 1 with 3-(phe-
nylimino)indolin-2-one (14) afforded 15 which annulated with
formalin to give the corresponding spiro[indoline-3,40-pyrimi-
do[4,5-d]pyrimidine]-2,50,70(60H,80H)-trione (16). The mass
spectrum of compound 15 showed the molecular ion peak at
m/z 378 (M++1, 17). Once more, the synthesis of pyrimi-
do[4,5-d]pyrimidine-5-thione derivative 18 was conducted.
Hence, reaction of 1 with phenyl isothiocyanate afforded com-
pound 17. Annulation of 17 with benzaldehyde gave the target
product 18 (Scheme 4) which was established on the basis of its
analytical and spectral data. The mass spectrum of 17 showed
the molecular ion peak at m/z 290 (M+, 0.13%).
In conclusion, 6-amino-1,3-dimethylpyrimidine-2,4(1H,3H)-
dione (1) contain enamino system including bis-nucleophilic3 N
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Scheme 4 Synthesis of pyrimido[4,5-d]pyrimidine derivatives 13, 16 and 18.
120 W.S. Hamama et al.centers as amino group and beta position of amino group which
reacted with twomoles of different aldehydes to give dimethylol
followed by its reaction with one mole of primary amine via
double Mannich reaction. Eleven pyrimido[4,5-d]pyrimidine
derivatives and their related analogs were synthesized and
elucidated on the basis of elemental analyses and spectral data
(C.f. Experimental section). Newly prepared compounds were
obtained through reaction of 1 with primary amines and form-
aldehyde or aldehydes in a molar ratio (1:1:2). Bis-pyrimi-
do[4,5-d]pyrimidine ring systems 6–8 were obtained through
reaction of 1 with primary amines and formaldehyde in molar
ration (2:1:4). Furthermore, transamination of 9 with ammo-
nium carbonate gave symmetrical bis-Mannich base 10 which
upon reaction with formalin gave the target pyrimido[4,5-
d]pyrimidine 11. In other routes, compound 1 reacted with
Schiff bases followed by reaction with formaldehyde or reacted
with phenyl isothiocyanate followed by reaction with benzalde-
hyde. Yields are low (around 30%) for most of the substrates
except for compound 4 (93%). because aldehyde and amine
contains electron donating group ‘‘OCH3’’ which activate the
two substrates then activate the reaction and therefore gave
high yield.References
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